A case of novel NFKB2 variant with hypertensive emergency and nephrotic syndrome leading to CKD 5D.
Toru NagataKenji NakagawaFumitoshi TsurumiKen WatanabeTomomi EndoAtsuko HataPublished in: Pediatric nephrology (Berlin, Germany) (2024)
Nuclear factor kappa B (NF-κB) family plays a central role in the human immune system. Heterozygous variants in NFKB2 typically cause immunodeficiency with various degrees of central adrenal insufficiency, autoimmunity, and ectodermal dysplasia. No reported case has presented kidney failure as an initial symptom. Moreover, documentation of kidney involvement of this disease is limited. CASE DIAGNOSIS: A 2-year-old female who presented with dyspnea and hypertensive emergency in the setting of new-onset nephrotic syndrome with acute-on chronic kidney injury with resultant chronic kidney disease (CKD) was found to have a novel heterozygous N-terminal variant in NFKB2 (c.880del: p. Tyr294Ilefs*4) with mild hypogammaglobulinemia, but no adrenal insufficiency or ectodermal dysplasia. She became dialysis-dependent during her initial hospitalization and developed CKD stage 5D, requiring continued peritoneal dialysis. She is currently awaiting kidney transplantation. CONCLUSIONS: Whether nephrotic syndrome or kidney injury or failure is the primary symptom of this variant or secondary to some event remains unknown. Further case accumulation is warranted.
Keyphrases
- chronic kidney disease
- end stage renal disease
- nuclear factor
- peritoneal dialysis
- kidney transplantation
- toll like receptor
- blood pressure
- emergency department
- public health
- early onset
- healthcare
- endothelial cells
- liver failure
- signaling pathway
- oxidative stress
- dna methylation
- copy number
- cell proliferation
- immune response
- inflammatory response
- drug induced
- patient reported
- genome wide